Embla

London, United Kingdom

Nutrition & Food as Medicine Consumer Wellness Healthy Living

The biggest lie in obesity care is that there are easy fixes.This is an industry addicted to over-simplification, misinformation and inauthentic stock photos. None of it is real.Weight loss is complicated because people are. It’s tied to genetics, personality, lifestyle, hormones, habits, relationships and psychology.Embla exists to challenge the world’s reductive approach to weight loss, to reduce the harm to people’s health and our health system. We do this by combining science, compassion and service excellence. Highly personalised weight loss care that works because it’s precisely as complicated as you are. Today, our program serves members in both Denmark and the UK, guiding thousands toward healthier lives.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Embla on @MedStartr Today #ObesityOverweight #WeightManagementObesity #MetabolicHealth #CardiometabolicConditions #NutritionFoodAsMedicine #ConsumerWellness #HealthyLiving #MedMo #MedStartrVentures

https://www.medstartr.ai/s/8o5x5AenjS0

Get Involved in Embla

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2021
Website: www.joinembla.com/

Disease Areas

Obesity & Overweight Weight Management/Obesity Metabolic Health Cardiometabolic Conditions

Technologies

Personalized CoachingBehavior Change TechnologyNutrition Software

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Embla?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.